Partial remission: A common outcome in older adults treated for major depression

Geriatrics

Volumn 61, Issue 4, 2006, Pages 22-26

  Hybels, Celia F ^a   Blazer, Dan G ^a,b   Steffens, David C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b IL   (United States)

Author keywords

Antidepressants; Drugs discussed: Selective serotonin reuptake inhihibitors; Dysthymia; Major depression; Partial remission; Well being

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DULOXETINE; LITHIUM; MIRTAZAPINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; DAILY LIFE ACTIVITY; DYSTHYMIA; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; PATIENT COUNSELING; PATIENT SAFETY; PROBLEM SOLVING; PSYCHOEDUCATION; PSYCHOTHERAPY; SOCIAL ASPECT; SOCIAL SUPPORT; STRESS; SYMPTOMATOLOGY; TREATMENT OUTCOME; WELLBEING;

AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; PSYCHOTHERAPY; RECURRENCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 33645940929     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58(3):249-65.
2. German PS, Shapiro S, Skinner EA. Mental health of the elderly: Use of health and mental health services. J Am Geriatr Soc 1985; 33(4):246-52.
3. Brodaty H, Harris L, Peters K, et al. Prognosis of depression in the elderly: a comparison with younger patients. Br J Psychiatry 1993; 163:589-96.
4. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry 1991; 148(2):174-8.
5. Alexopoulos GS, Meyers BS, Young RC, et al. Recovery in geriatric depression. Arch Gen Psychiatry 1996; 53(4):305-12.
6. Steffens DC, McQuoid DR, Krishnan KR. Partial response as a predictor of outcome in geriatric depression. Am J Geriatr Psychiatry 2003; 11(3):340-8.
7. Zweig RA, Hinrichsen GA. Factors associated with suicide attempts by depressed older adults: a prospective study. Am J Psychiatry 1993; 150(11):1687-92.
8. Folstein MF, Folstein SE, McHugh PR. "Minimental state": a practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res 1975; 12(3):189-98.
9. Hybels CF, Blazer DG, Steffens DC. Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia. Am J Geriatr Psychiatry 2005; 13(8):713-21.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, 4th ed. Washington, DC: American Psychiatric Association; 1994.
11. Steffens DC, McQuoid DR, Krishnan KR. The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. Psychopharmacol Bull 2002; 36(2);58-68.
12. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-9.
13. Kocsis JH, Rush AJ, Markowitz JC, et al. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacol Bull 2003; 37(4):73-87.
14. Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP, Ross RW. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 2001; 7(6):361-76.
15. Mulsant BH, Pollock BG. Treatment-resistant depression in late life. J Geriatr Psychiatry Neural 1998; 11(4):186-93.
16. Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry 2000; 45(5):476-81.
17. Joffe RT, Levitt AJ, Sokolov ST, Young LT. Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 1996; 57(3):114-5.
18. Bschor T, Lewitzka U, Sasse J, Adli M, Koberle U, Bauer M. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 2003; 36(Suppl 3):S230-4.
19. DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol 2003; 23(1):27-30.
20. Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 2002; 51(2):183-8.
21. Hirschfeld RM. The use of mirtazapine in difficult-to-treat patient populations. Hum Psychopharmacol 2002; 17(Suppl 1):S33-6.
22. Whyte EM, Basinski J, Farhi P, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65(12):1634-41.
23. Nelson JC, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Kennedy JS. Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry 2005; 13(3):227-35.
24. Fava M. Management of nonresponse and Intolerance: switching strategies. J Clin Psychiatry 2000; 61(Suppl 2):10-2.
25. Reynolds CF 3rd, Frank E, Perrel J, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 218(1):39-45.
26. Lynch TR, Aspnes AK. Individual and group psychotherapy. In: Blazer DG, Steffens DC, Busse EW, eds. American Psychiatric Publishing Textbook of Geriatric Psychiatry. Washington, DC: American Psychiatric Publishing, Inc; 2004:443-58.
27. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354(11):1130-8.